Doctor Care Anywhere Group PLC · ASX:DOC
Doctor Care Anywhere — Non-Deal Roadshow (September 2025)
15 slides from Doctor Care Anywhere's roadshow presentation, Sep 11, 2025
Slide 1: Doctor Care Anywhere Investor Roadshow in Australia
11 September 2025 Doctor Care Anywhere Investor Roadshow in Australia Doctor Care Anywhere Group PLC (ASX:DOC) (“Doctor Care Anywhere” or “the Company”) will hold its upcoming investor roadshow in Australia from 15–19 September 2025. Chief Executive Officer Laura O’Riordan and Chief Product Officer
Slide 2: Right Time, Right Strategy – Unlocking Opportunity
For personal use only Right Time, Right Strategy – Unlocking Opportunity September 2025 1 © 2025 Doctor Care Anywhere
Slide 3: Important Notice and Disclaimer
Important Notice and Disclaimer This presentation is for information purposes only and it is Neither the Company nor any of its directors, officers, not financial product or investment advice. The employees, advisors, associated persons or subsidiaries This presentation may contain forward-looking s
Slide 4: Meet the Team
Meet the Team For personal use only Laura O’Riordan Andrew Bellingham Chief Executive Officer Chief Product & Proposition Officer Laura O’Riordan, a qualified nurse; joined Andrew has been a qualified pharmacist for over Doctor Care Anywhere from her most recent 20 years & has been working in the he
Slide 5: Our Winning Formula
Our Winning Formula For personal use only £19.2m 350k 650 1.2m Revenue up 1.6% BAU Consultations in 1H25 Employed Staff Activated Lives 24/7 +90% 10+ Years 90 seconds 365 Day 'Excellent’ Operating Appointment Operation Clinical Quality Experience Booking Time 4
Slide 6: Financial Highlights 1H25
Financial Highlights 1H25 Breakthrough year for sustainable financial performance For personal use only Underlying EBITDA £4.8m £19.2m profit of (A$9.9m) Revenue (A$39.8m) £2.9m (A$6.0m) +1.6% BAU vs PCP Cash in hand at 30 June Up from £0.0m in PCP 2025 63% 51% £0.4m Underlying gross Underlying prof
Slide 7: Drive Continued Growth
Drive Continued Growth Double our revenue and generate at least 15% EBITDA in 3 to 5 years Annual revenue (£m)* Underlying EBITDA (£m) 15.0 For personal use only 90 80 10.0 70 5.0 60 50 - 40 FY22 FY23 FY24 1H25 3 to 5 Years (5.0) 30 20 (10.0) 10 (15.0) - FY22 FY23 FY24 1H25 3 to 5 Years (20.0) Aim
Slide 8: Key Priorities – 3 to 5 years
Key Priorities – 3 to 5 years Strengthen and expand current relationships Become a more strategic partner to our customers by helping them to delight their users, solve For personal use only business challenges, reduce costs, and unlock new service opportunities. Sign transformational new business G
Slide 9: Strengthen Existing Client Relationships
Strengthen Existing Client Relationships New proposition development and service expansion will ignite customer and revenue growth Existing clients Expand customer value through new service offerings 3.5 million For personal use only customers e.g. Health Assessments & GLP-1 Revenue & Customer Growt
Slide 10: Signing Transformational New Deals
Signing Transformational New Deals Our business uniquely turns obstacles into solutions which is driving new deal opportunities For personal use only Increased NHS Pressure 24/7 operation with 100% of patients seen Struggling NHS service with average primary within 24 hours care wait of 2 weeks (2 h
Slide 11: DCA's Wide Range of Services
DCA's Wide Range of Services Solutions to a meet a market-wide health need For personal use only Enhanced clinical support Digital primary care clinical intervention Digital led assessment & pathway navigation 31.3 million total working population employer’s User Total population of need to support
Slide 12: Margin Expansion 1: Gross Margin
Margin Expansion 1: Gross Margin We can further reduce our cost to serve and increase gross margin % Skills Mix – Impact on GM % For personal use only ppt Increase Increase skills mix Currently 60:40 2024 H1 2025 GM GM GP: Other Clinicians 58% 63% Variable length appointments ppt Increase Varied len
Slide 13: Margin Expansion 2: Overheads
Margin Expansion 2: Overheads Significant opportunity to reduce non-operating costs Targeting a reduction in non-operating costs from approximately 43% to 20% of revenue over For personal use only the next 3 to 5 years Efficiency Simplification Transformation Procurement Reduce 3rd party Reduce spen
Slide 14: Accelerate Digital Delivery to Drive Scalable Growth
Accelerate Digital Delivery to Drive Scalable Growth Product roadmap to transform primary care with technology driven solutions for value-based care H1 2025 H2 2025 H1 2026 H2 2026 For personal use only Pharmacy fulfilment Asynchronous AI Navigation Patient journey differentiated offer (1 ho
Slide 15: Strong Performance, Unrealised Potential
Strong Performance, Unrealised Potential Executing today, scaling tomorrow — market value yet to catch up For personal use only DCA has significant growth opportunity Efficient, Well-Managed, and Cost-Effective business model Demonstrated consistent and strong year on year financial progress
Doctor Care Anywhere Group — Non-Deal Roadshow (September 2025) on 6ix